| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |